XML 21 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
As Previously Reported [Member]
Common Stock [Member]
Common Stock [Member]
As Previously Reported [Member]
Capital in Excess of Par Value [Member]
Capital in Excess of Par Value [Member]
As Previously Reported [Member]
Retained Earnings [Member]
Retained Earnings [Member]
As Previously Reported [Member]
Accumulated Other Comprehensive Earnings (Loss) [Member]
Accumulated Other Comprehensive Earnings (Loss) [Member]
As Previously Reported [Member]
Noncontrolling Interests [Member]
Noncontrolling Interests [Member]
As Previously Reported [Member]
Adoption of Topic 606 (Accounting Standards Update 2014-09 [Member]) at Dec. 31, 2015 $ 127.5           $ 125.3       $ 2.2  
Beginning Balance at Dec. 31, 2015   $ 3,688.2   $ 176.9   $ 3,209.4   $ 774.5   $ (522.5)   $ 49.9
Beginning Balance, as restated at Dec. 31, 2015 3,815.7   $ 176.9   $ 3,209.4   899.8   $ (522.5)   52.1  
Beginning Balance (in shares) at Dec. 31, 2015     176.9 176.9                
Net earnings 430.3 [1] 445.0         396.8       33.5  
Net purchase of subsidiary shares from noncontrolling interests 8.3                   8.3  
Dividends paid to noncontrolling interests (34.1)                   (34.1)  
Net change in pension asset/liability, net of taxes (4.4) [1] (4.4)             (4.4)      
Foreign currency translation (220.4)               (224.8)   4.4  
Change in fair value of derivative instruments, net of taxes (4.9) [1] (4.9)             (4.9)      
Compensation expense related to stock option plan grants 14.7       14.7              
Tax impact from issuance of common stock 6.5       6.5              
Common stock issued in: Nine purchase transactions 91.6   $ 2.0   89.6              
Common stock issued in: Nine purchase transactions (In Shares)     2.0                  
Stock option plans 29.7   $ 1.1   28.6              
Stock option plans (in shares)     1.1                  
Employee stock purchase plan 15.9   $ 0.4   15.5              
Employee stock purchase plan (in shares)     0.4                  
Deferred compensation and restricted stock 0.1   $ 0.2   (0.1)              
Deferred compensation and restricted stock (in shares)     0.2                  
Common stock repurchases (101.0)   $ (2.3)   (98.7)              
Common stock repurchases (in shares)     (2.3)                  
Cash dividends declared on common stock (272.5)           (272.5)          
Ending Balance at Dec. 31, 2016 3,775.5 3,655.8 $ 178.3   3,265.5   1,024.1 916.4 (756.6) (763.6) 64.2 59.2
Ending Balance (in shares) at Dec. 31, 2016     178.3                  
Beginning Balance, as restated at Dec. 31, 2016 3,775.5           1,024.1   (756.6)   64.2  
Net earnings 516.9 [1] 499.2         481.3       35.6  
Net purchase of subsidiary shares from noncontrolling interests (2.1)                   (2.1)  
Dividends paid to noncontrolling interests (34.4)                   (34.4)  
Net change in pension asset/liability, net of taxes 4.3 [1] 4.3             4.3      
Foreign currency translation 181.7               180.9   0.8  
Change in fair value of derivative instruments, net of taxes 16.0 [1] 16.0             16.0      
Compensation expense related to stock option plan grants 17.3       17.3              
Common stock issued in: Nine purchase transactions 60.6   $ 1.0   59.6              
Common stock issued in: Nine purchase transactions (In Shares)     1.0                  
Stock option plans $ 41.1   $ 1.3   39.8              
Stock option plans (in shares) 1.3   1.3                  
Employee stock purchase plan $ 19.3   $ 0.4   18.9              
Employee stock purchase plan (in shares)     0.4                  
Deferred compensation and restricted stock 4.8   $ 0.3   4.5              
Deferred compensation and restricted stock (in shares)     0.3                  
Common stock repurchases (17.7)   $ (0.3)   (17.4)              
Common stock repurchases (in shares)     (0.3)                  
Cash dividends declared on common stock (283.6)           (283.6)          
Ending Balance at Dec. 31, 2017 4,299.7 [1] $ 4,164.9 $ 181.0   3,388.2   1,221.8 $ 1,095.9 (555.4) $ (559.9) 64.1 $ 59.7
Ending Balance (in shares) at Dec. 31, 2017     181.0                  
Beginning Balance, as restated at Dec. 31, 2017 4,299.7           1,221.8   (555.4)   64.1  
Reclassification of the income tax effects within accumulated other comprehensive loss related to the Tax Act             6.6   (6.6)      
Net earnings 675.9           633.5       42.4  
Net purchase of subsidiary shares from noncontrolling interests (0.7)       (5.0)           4.3  
Dividends paid to noncontrolling interests (38.0)                   (38.0)  
Net change in pension asset/liability, net of taxes (10.3)               (10.3)      
Foreign currency translation (199.7)               (197.7)   (2.0)  
Change in fair value of derivative instruments, net of taxes (15.6)               (15.6)      
Compensation expense related to stock option plan grants 13.7       13.7              
Common stock issued in: Nine purchase transactions 61.6   $ 0.8   60.8              
Common stock issued in: Nine purchase transactions (In Shares)     0.8                  
Stock option plans $ 58.6   $ 1.6   57.0              
Stock option plans (in shares) 1.6   1.6                  
Employee stock purchase plan $ 23.3   $ 0.4   22.9              
Employee stock purchase plan (in shares)     0.4                  
Deferred compensation and restricted stock 15.8   $ 0.3   15.5              
Deferred compensation and restricted stock (in shares)     0.3                  
Common stock repurchases (11.3)   $ (0.1)   (11.2)              
Common stock repurchases (in shares)     (0.1)                  
Cash dividends declared on common stock (303.3)           (303.3)          
Ending Balance at Dec. 31, 2018 $ 4,569.7   $ 184.0   $ 3,541.9   $ 1,558.6   $ (785.6)   $ 70.8  
Ending Balance (in shares) at Dec. 31, 2018     184.0                  
[1] See Note 3 - Revenues from Contracts with Customers for additional information about the restatements related to Topic 606.